Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stevanato Group S.P.A. (NY: STVN )

27.89 -0.34 (-1.22%)
Streaming Delayed Price Updated: 12:13 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Stevanato Group S.P.A.

< Previous 1 2 3 Next >
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group appoints Ugo Gay as Chief Operations Officer
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Public Offering of Ordinary Shares
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing
From Stevanato Group
Via Business Wire
Stevanato Group to Present at the Jefferies London Healthcare Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports Third Quarter 2023 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Voting Results from its Extraordinary General Meeting
From Stevanato Group S.p.A.
Via Business Wire
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
Stevanato Group to Livestream Inaugural Capital Markets Day on September 27, 2023
From Stevanato Group
Via Business Wire
Stevanato Group Reports Second Quarter 2023 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Second Quarter 2023 Financial Results on July 28, 2023
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Presents Vertiva™, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (up to 10mL)
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Change in Ex-Dividend Date for its Dividend
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports First Quarter 2023 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at BofA Securities Healthcare Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth
From Stevanato Group
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.